Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

TLX SP ?4.5 RT, SLActive? 10mm, RXD: medical device reports filed with FDA

702 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

702
device reports naming the brand
0% of all MAUDE reports · about 134 a year
195
reports, 12 months to August 2026
165 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

702 medical device reports received by FDA name the brand "TLX SP ?4.5 RT, SLActive? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from April 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

195 reports arrived in the 12 months to August 2026, up 18% from 165 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (66.1%), loss of osseointegration (20.4%) and difficult to insert (0.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02345Sep 2021: 0Oct 2021: 2Nov 2021: 2Dec 2021: 22022Jan 2022: 4Feb 2022: 3Mar 2022: 7Apr 2022: 7May 2022: 6Jun 2022: 4Jul 2022: 10Aug 2022: 13Sep 2022: 1Oct 2022: 10Nov 2022: 7Dec 2022: 112023Jan 2023: 8Feb 2023: 7Mar 2023: 5Apr 2023: 5May 2023: 14Jun 2023: 13Jul 2023: 8Aug 2023: 16Sep 2023: 6Oct 2023: 18Nov 2023: 18Dec 2023: 152024Jan 2024: 7Feb 2024: 8Mar 2024: 18Apr 2024: 22May 2024: 19Jun 2024: 12Jul 2024: 13Aug 2024: 16Sep 2024: 6Oct 2024: 14Nov 2024: 23Dec 2024: 122025Jan 2025: 6Feb 2025: 6Mar 2025: 16Apr 2025: 9May 2025: 0Jun 2025: 45Jul 2025: 17Aug 2025: 11Sep 2025: 11Oct 2025: 8Nov 2025: 19Dec 2025: 192026Jan 2026: 10Feb 2026: 8Mar 2026: 10Apr 2026: 21May 2026: 18Jun 2026: 29Jul 2026: 21Aug 2026: 21

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0851702021: 1120212022: 8320222023: 13320232024: 17020242025: 16720252026: 1382026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%702
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report90.9%638
Voluntary report0%0
User facility report0%0
Distributor report9.1%64
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate46466.1%62.8%
Loss of osseointegration14320.4%22.4%
Difficult to insertthe device was hard to insert60.9%0.4%
Fracturea broken bone30.4%1.6%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis26337.5%
Painpain, site not specified13218.8%
Inflammationinflammation294.1%
Hemorrhage/blood loss/bleeding253.6%
Swelling/ edema243.4%
Sinus perforation152.1%
Hyperresponsive to stimuli111.6%
Fistula81.1%
Abscessa collection of pus60.9%
Hypersensitivity/allergic reaction30.4%
Numbnessnumbness20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTLX SP ?4.5 RT, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports7023,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer90.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about TLX SP ?4.5 RT, SLActive? 10mm, RXD reports

How many FDA reports name TLX SP ?4.5 RT, SLActive? 10mm, RXD?

702 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 195 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (66.1%), loss of osseointegration (20.4%), difficult to insert (0.9%), fracture (0.4%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (90.9%) and distributor reports (9.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that TLX SP ?4.5 RT, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.